Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
1(25%)
Results Posted
100%(1 trials)

Phase Distribution

Ph phase_2
2
50%
Ph phase_4
1
25%

Phase Distribution

0

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution3 total trials
Phase 2Efficacy & side effects
2(66.7%)
Phase 4Post-market surveillance
1(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(2)
Completed(1)
Other(1)

Detailed Status

unknown1
Completed1
Active, not recruiting1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (66.7%)
Phase 41 (33.3%)

Trials by Status

unknown125%
completed125%
active_not_recruiting125%
not_yet_recruiting125%

Recent Activity

1 active trials
Showing 4 of 4
active_not_recruitingphase_2

A Phase II Trial of RAB001 (LLP2A-Alendronate) for Steroid-Induced Early-Stage Osteonecrosis of the Femoral Head

NCT07471880
not_yet_recruitingphase_2

Romosozumab Effects on Bone Density, Muscle Mass, and Spine Surgery Outcomes

NCT06973109
completed

Alendronate in Juvenile Osteoporosis

NCT00920075
unknownphase_4

Alendronate for Vascular Calcification in Peritoneal Dialysis Patients?

NCT00299572

Clinical Trials (4)

Showing 4 of 4 trials
NCT07471880Phase 2

A Phase II Trial of RAB001 (LLP2A-Alendronate) for Steroid-Induced Early-Stage Osteonecrosis of the Femoral Head

Active Not Recruiting
NCT06973109Phase 2

Romosozumab Effects on Bone Density, Muscle Mass, and Spine Surgery Outcomes

Not Yet Recruiting
NCT00920075

Alendronate in Juvenile Osteoporosis

Completed
NCT00299572Phase 4

Alendronate for Vascular Calcification in Peritoneal Dialysis Patients?

Unknown

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4